On Demand - Launching Therapies in the Time of COVID-19

Recorded Content

Member: $10.00
Non-Member: $15.00Your price

Published: 10/27/2020 12:00:00 AM

Original air date: 27 October 2020
Note: Windows Media Player 9 or higher is needed to view the recording.

The New England HBA Commercial Affinity Group is pleased to present this year’s panel discussion on “Launching Therapies in the Time of COVID-19” next in the series as a follow-up to our 2019 panel event, “Launching Products Successfully - What Does It Really Take?”

COVID-19 has changed the healthcare environment and the way biopharma companies engage key stakeholders, particularly with healthcare professionals and patients. In this encore panel event, we hear from accomplished commercial leaders about how COVID-19 is shaping the way biopharmas launch new therapies. Topics include:

• How COVID-19 is impacting the provision of healthcare including diagnosis and treatment
• How patient and healthcare provider needs and expectations are changing treatment pathways
• Which are the important channels for launching in this environment
• Examples of launches since the onset of COVID-19, challenges and opportunities

Registration information
Event is open to: HBA Members and Nonmembers